This inventor holds 1 USPTO granted patent. Top assignee: Hamari Chemicals, Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Reiko Natsuki: Innovator in Diabetes Treatment
Introduction
Reiko Natsuki is a prominent inventor based in Yawata, Japan. She has made significant contributions to the field of diabetes treatment through her innovative research and development. Her work focuses on the use of zinc tranexamate, a compound that has shown promise in managing diabetes effectively.
Latest Patents
Reiko Natsuki holds a patent for the use of zinc tranexamate in the treatment of diabetes. This patent discloses a new application of the zinc tranexamate compound, which aids in slowing down the absorption of glucose from the digestive tract by inhibiting α-glucosidase in vivo. This compound is particularly effective for individuals suffering from insulin-resistant type II diabetes. She has 1 patent to her name, showcasing her innovative approach to addressing a critical health issue.
Career Highlights
Natsuki is associated with Hamari Chemicals, Ltd., where she continues to explore and develop new therapeutic solutions. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Throughout her career, Reiko has collaborated with notable colleagues, including Hajime Fujimura and Masakatsu Nozaki. These partnerships have further enhanced her research efforts and contributed to the advancement of diabetes treatment.
Conclusion
Reiko Natsuki's work in the field of diabetes treatment exemplifies the impact of innovative research on healthcare. Her contributions through her patent on zinc tranexamate highlight the importance of continued exploration in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile